Nucor Corporation enters the final stretch of August with its options defensiveness intact — and the broader steel sector now joining the retreat.
The put/call ratio remains the sharpest signal on the tape. It spiked further to 0.76 on August 18, a reading that still runs more than four standard deviations above its 20-day mean of 0.61 and remains close to the 52-week high of 0.81. This is the same defensive posture flagged earlier in the week — but it has held rather than faded, suggesting the demand for downside protection is not a one-day flush. The stock fell 3.1% on Tuesday to $264.19, extending a 2.9% weekly decline, even after a strong 11.7% gain over the prior month. The options market was, in that sense, early and right.
The lending market continues to tell a completely different story. Availability remains effectively unlimited — more than 225 million shares sit in the lending pool against roughly 3.7 million shorted. Short interest at 1.6% of the free float is near its lowest level in six weeks, having shed another 7.7% over the past week. Cost to borrow has collapsed to just 0.09%, down from 0.45% a week ago and as low as it has been in months. There is no squeeze pressure here, no short-side conviction building — the lending market is about as loose as it gets.
The sector context adds weight to the caution. Tuesday's session was rough across steel: STLD fell 3.2% on the day and is down 5.3% on the week, CLF dropped 3.5% — worse than NUE — while RS held up better, off just 1.5%. NUE is broadly in line with the sector on a day basis, which somewhat dilutes the stock-specific narrative, but the magnitude and persistence of the options skew remains unusual relative to peers.
The Street was constructive into the weakness. Following Q2 results in late July, Wells Fargo and Barclays both raised targets to $297 and $295 respectively, maintaining Overweight ratings. BMO lifted to $295. The mean consensus target sits near $284 — above current levels, implying roughly 7% potential upside from here. UBS held its Neutral rating but raised its target to $256, still below the current price, keeping the lone sceptic on the Street visible. Factor scores reinforce the relative quality of the setup: EPS momentum ranks in the 88th percentile on a 30-day basis and the 87th on a 90-day view, while the dividend score sits at the 95th percentile — a reminder that NUE remains one of the more shareholder-friendly names in the space regardless of near-term price action. The short score of 30.7 has drifted lower all week, consistent with the easing short interest.
Insider flows lean one direction. Four separate executive vice presidents and the President/COO have sold shares in the past six weeks — the most recent a pair of transactions from EVP Allen Behr on August 14 totalling just over $2.1 million at prices around $274. Combined, the 90-day net selling runs to approximately $18.8 million in value. None of the trades are individually alarming at these significance scores (2-3 out of 10), and scheduled selling programmes can explain much of it, but the absence of any buying into the month's rally is worth noting.
The next scheduled catalyst is the Q3 earnings call on November 5. Between now and then, the key watch is whether the put/call ratio normalises back toward its 0.61 mean — or whether it holds elevated as a leading indicator of sector sentiment shifting structurally more cautious into year-end.
See the live data behind this article on ORTEX.
Open NUE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
